Literature DB >> 9012361

Overexpression of the heme oxygenase gene in renal cell carcinoma.

A I Goodman1, M Choudhury, J L da Silva, M L Schwartzman, N G Abraham.   

Abstract

Heme oxygenase (HO) activity has been implicated in the regulation of renal function and cell growth in normal and disease states. Expression of HO genes has been shown to regulate important hemoprotein(s) such as cytochrome P450. In the present study, HO activity was measured in samples of human adenocarcinoma, juxtatumor, and normal renal tissues. The samples were histologically examined to verify the malignant and normal nature. HO activity was 4-fold higher in the adenocarcinoma than in either normal or juxtatumor tissues. We designed a reverse transcriptase-polymerase chain reaction (RT-PCR) method to assess the presence of HO-1 and HO-2 mRNA in biopsy samples of various human renal tissues. Total RNA from renal samples was reverse transcribed and amplified simultaneously by PCR using specific primers for HO-1 and HO-2. Results show that both HO-1 and HO-2 mRNAs were expressed in all renal tissues examined and that HO-1 appeared to be amplified more than HO-2. Northern blot analysis revealed that HO-1 mRNA was elevated by several-fold in adenocarcinoma compared with juxtatumor or normal tissues. In contrast, no differences in HO-2 mRNA levels were observed using either RT-PCR or Northern blot. Cytochrome P450 arachidonic acid epoxygenase and omega-hydroxylase activities were markedly reduced in the tumor tissues, whereas, in the juxtatumor tissue, cytochrome P450 omega-hydroxylase activity was significantly increased. Northern blot analysis using cytochrome P450 cDNA probe 4A2 cDNA for the omega-hydroxylase gene family revealed that mRNA levels for omega-hydroxylase transcripts were significantly decreased in the adenocarcinoma compared with juxtatumor. The decrease in cytochrome P450 4All mRNA levels correlated with a decrease in the arachidonic acid omega-hydroxylation metabolite, 20-HETE. The production of 20-HETE was significantly higher in juxtatumor in agreement with omega-hydroxylase mRNA. Higher levels of HO-1 may be a contributing factor for the undetectable levels of cytochrome P450 arachidonic acid metabolites, 20-HETE, in the adenocarcinoma. Our results suggest that increased generation of mitogenic activities by omega-hydroxylase and 20-HETE in the juxtatumor may be a contributing factor in the development and growth of neoplastic tissues, and the induction of HO in the tumor tissue may be an attempt to limit oxidative injury caused by the cytochrome P450 metabolites and other oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9012361     DOI: 10.3181/00379727-214-44069

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  54 in total

Review 1.  EET signaling in cancer.

Authors:  Dipak Panigrahy; Emily R Greene; Ambra Pozzi; Dao Wen Wang; Darryl C Zeldin
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 2.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

3.  Stimulated upregulation of HO-1 is associated with inadequate response of gastric and ovarian cancer cell lines to hyperthermia and cisplatin treatment.

Authors:  Vaidotas Cesna; Arturas Sukovas; Aldona Jasukaitiene; Giedre Silkuniene; Saulius Paskauskas; Zilvinas Dambrauskas; Antanas Gulbinas
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

4.  Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib.

Authors:  Ignazio Barbagallo; Cesarina Giallongo; Giovanni Li Volti; Alfio Distefano; Giuseppina Camiolo; Marco Raffaele; Loredana Salerno; Valeria Pittalà; Valeria Sorrenti; Roberto Avola; Michelino Di Rosa; Luca Vanella; Francesco Di Raimondo; Daniele Tibullo
Journal:  Mol Neurobiol       Date:  2018-06-10       Impact factor: 5.590

Review 5.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 6.  Heme oxygenase-1 in tumors: is it a false friend?

Authors:  Alicja Jozkowicz; Halina Was; Jozef Dulak
Journal:  Antioxid Redox Signal       Date:  2007-12       Impact factor: 8.401

7.  Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma.

Authors:  Norberto A Gandini; María E Fermento; Débora G Salomón; Diego J Obiol; Nancy C Andrés; Jean C Zenklusen; Julián Arevalo; Jorge Blasco; Alejandro López Romero; María M Facchinetti; Alejandro C Curino
Journal:  Tumour Biol       Date:  2014-03

8.  Autophagy inhibition promotes epithelial-mesenchymal transition through ROS/HO-1 pathway in ovarian cancer cells.

Authors:  Zhe Zhao; Jing Zhao; Jing Xue; Xinrui Zhao; Peishu Liu
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

9.  Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.

Authors:  H Li; J T Wood; K M Whitten; S K Vadivel; S Seng; A Makriyannis; H K Avraham
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

10.  Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo.

Authors:  Philipp Nuhn; Beat M Künzli; René Hennig; Tomas Mitkus; Tadas Ramanauskas; Rainer Nobiling; Stefan C Meuer; Helmut Friess; Pascal O Berberat
Journal:  Mol Cancer       Date:  2009-06-09       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.